Status:
COMPLETED
Freeze-dried Kale to Reduce Metabolic Risk in Saudi Subjects
Lead Sponsor:
Chair for Biomarkers of Chronic Diseases
Collaborating Sponsors:
King AbdulAziz City for Science and Technology
Conditions:
Obesity
Metabolic Disease
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
Whilst obesity represents a key risk factor for the development of metabolic disease and further premature mortality, the actual type of diet may provide the 'primary insults' for inflammation affecti...
Detailed Description
Subjects Selection: For this study we will recruit a total of 100 obese age matched non-diabetic Saudi women, (age 18-40 years; BMI 30-40Kg/m2) through college clinics in applied medical sciences col...
Eligibility Criteria
Inclusion
- Obese (BMI 30-40Kg/m2 and above)
- Aged 18-40 years
- Saudi nationality
- Female
Exclusion
- Age under 18 or above 40 years
- Any medical/endocrine problem that could affect energy expenditure (e.g. thyroid problems, Cushing's syndrome)
- Those with chronic inflammatory disorders like rheumatoid arthritis, or long term use of steroids or other immunomodulatory like cyclosporine, azathioprine; severe depression or any psychiatric illness, claustrophobia or needle phobia.
- Males
- Expatriates
Key Trial Info
Start Date :
September 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 28 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04904601
Start Date
September 15 2021
End Date
September 28 2022
Last Update
February 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Community Health Department, Applied Medical Sciences, King Saud University
Riyadh, Riyadh Region, Saudi Arabia, 11451